GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wanbangde Pharmaceutical Holding Group Co Ltd (SZSE:002082) » Definitions » Long-Term Debt

Wanbangde Pharmaceutical Holding Group Co (SZSE:002082) Long-Term Debt : ¥181 Mil (As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Wanbangde Pharmaceutical Holding Group Co Long-Term Debt?

Wanbangde Pharmaceutical Holding Group Co's Long-Term Debt for the quarter that ended in Mar. 2025 was ¥181 Mil.

Wanbangde Pharmaceutical Holding Group Co's quarterly Long-Term Debt increased from Sep. 2024 (¥81 Mil) to Dec. 2024 (¥104 Mil) and increased from Dec. 2024 (¥104 Mil) to Mar. 2025 (¥181 Mil).

Wanbangde Pharmaceutical Holding Group Co's annual Long-Term Debt declined from Dec. 2022 (¥135 Mil) to Dec. 2023 (¥82 Mil) but then increased from Dec. 2023 (¥82 Mil) to Dec. 2024 (¥104 Mil).


Wanbangde Pharmaceutical Holding Group Co Long-Term Debt Historical Data

The historical data trend for Wanbangde Pharmaceutical Holding Group Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wanbangde Pharmaceutical Holding Group Co Long-Term Debt Chart

Wanbangde Pharmaceutical Holding Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 746.80 237.00 135.20 81.51 104.00

Wanbangde Pharmaceutical Holding Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.24 55.34 80.80 104.00 181.21

Wanbangde Pharmaceutical Holding Group Co  (SZSE:002082) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Wanbangde Pharmaceutical Holding Group Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Wanbangde Pharmaceutical Holding Group Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Wanbangde Pharmaceutical Holding Group Co Business Description

Traded in Other Exchanges
N/A
Address
Dongliang Road 1688, Zhili Town, Zhejiang, Huzhou, CHN, 313008
Wanbangde Pharmaceutical Holding Group Co Ltd is mainly engaged in the pharmaceutical manufacturing and medical equipment-based health industry.
Executives
Zhao Shou Ming Directors, executives
Wang Tian Fang Director
Li Rong Fang Supervisors
Zhu Jian Xin Directors, executives
Yang Jin Rong Executives
Song Tie He Directors, executives
Song Jian Hua Executives
Pan Yun Chu Director
Yu Ju Ming Executives
Yang Mei Gen Executives
Tao Jian Feng Supervisors
Qian Shu Sheng Executives
Shen Bai Ming Director
Xu Yin Sheng Director
Shuang Zhi Wei Executives

Wanbangde Pharmaceutical Holding Group Co Headlines

No Headlines